APP and Alzheimer disease: To evaluate the therapeutic efficacy of gm-PBM and tc-PBM in alleviating AD pathology, we first examined whether these two light-based interventions could reduce β-amyloid (Aβ) plaque burden in the hippocampus (HIPP) and prefrontal cortex (PFC) of APP/PS1 transgenic AD mice.